Nurse Practitioner, Family · Norwalk, CT
NPI
1750400396
Since 2007
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
618 West Ave
Norwalk, CT, 06850
Phone (203) 852-9525
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,502
105 services
Medicare patients, 2024
28
Average age 64
Drug cost, 2024
$1.6M
2,311 prescriptions
Company payments, 2025
$3,765
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patricia R Garton was code 99213 (office e&m - established), 32 times for 22 patients. In total Patricia R Garton billed 105 services in 18 codes, and Medicare paid $4,502.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 32 | 22 | $56.81 | $1,818 |
By year: 2022 $7,980 for 328 services; 2023 $7,009 for 926 services; 2024 $4,502 for 105 services.
Medicare prescription drug claims, 2024
In 2024, the drug Patricia R Garton prescribed most often to Medicare patients was Dovato (Dolutegravir Sodium/Lamivudine), with 91 prescriptions and refills. In total Patricia R Garton wrote 2,311 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dovato Dolutegravir Sodium/Lamivudine | 91 | 91 | Under 11 | $252K |
| Rosuvastatin Calcium Generic | 89 | 97 | Under 11 | $498 |
| Valacyclovir Valacyclovir Hcl | 85 | 118 | 12 | $3,955 |
| Amlodipine Besylate Generic | 78 | 102 | 11 | $182 |
| Ozempic Semaglutide | 74 | 74 | Under 11 | $66K |
| Testosterone Generic | 73 | 73 | Under 11 | $8,290 |
| Lisinopril Generic | 66 | 92 | Under 11 | $282 |
| Alprazolam Generic | 66 | 66 | Under 11 | $301 |
| Juluca Dolutegravir/Rilpivirine | 62 | 62 | Under 11 | $201K |
| Tamsulosin Hcl Generic | 45 | 59 | Under 11 | $370 |
| Descovy Emtricitabine/Tenofov Alafenam | 43 | 43 | Under 11 | $87K |
| Farxiga Dapagliflozin Propanediol | 40 | 44 | Under 11 | $24K |
| Atorvastatin Calcium Generic | 38 | 54 | Under 11 | $391 |
| Vascepa Icosapent Ethyl | 38 | 38 | Under 11 | $12K |
| Vraylar Cariprazine Hcl | 37 | 37 | Under 11 | $50K |
Brand drugs: 897 claims; generic drugs: 1,380 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Patricia R Garton $3,765 ($3,765 in general payments such as food, travel and fees) from 15 companies. The largest payer was ViiV Healthcare Company with $1,498.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 49 | $1,498 |
| Gilead Sciences, Inc. GILD | 23 | $738 |
| Theratechnologies Inc. THTX | 9 | $376 |
| Abbott Laboratories ABT | 2 | $324 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $253 |
| Merck Sharp & Dohme LLC MRK | 7 | $242 |
| Abbvie Inc. ABBV | 3 | $76.96 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $69.36 |
| Antares Pharma, Inc. | 2 | $53.51 |
| Pfizer Inc. PFE | 2 | $39.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.